Pulmonary Alveolar Proteinosis Is a Disease of Decreased Availability of GM-CSF Rather than an Intrinsic Cellular Defect

By Thomassen M.J.   Yi T.   Raychaudhuri B.   Malur A.   Kavuru M.S.  

Clinical Immunology, Vol. 95, Iss. 2, 2000-05 ,pp. : 85-92

Academic Press

Access to resources Recommend Favorite

Incidence of GM-CSF Antibodies in Cancer Patients Receiving GM-CSF for Immunostimulation

By Ullenhag G.   Bird C.   Ragnhammar P.   Frödin J-E.   Strigård K.   Österborg A.   Thorpe R.   Mellstedt H.   Wadhwa M.  

Clinical Immunology, Vol. 99, Iss. 1, 2001-04 ,pp. : 65-74

Academic Press

Access to resources Recommend Favorite

The role of GM-CSF in enhancing immunotherapy of cancer

By Thorne Steve H  

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 817-819

Future Medicine

Access to resources Recommend Favorite

Effect of M-CSF, GM-CSF in adenovirus-mediated gene transfer into macrophages

By Shinozuka N.   Kamisasa N.   Akaishi T.   Minoshima T.   Watanabe T.   Matsumoto T.   Anzai H.   Koyama I.   Kyo S.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 963-963

Elsevier

Access to resources Recommend Favorite

Induction of Anti-Chlamydial Mucosal Immunity by Transcutaneous Immunization is Enhanced by Topical Application of GM-CSF

By  

Current Molecular Medicine, Vol. 5, Iss. 6, 2005-01 ,pp. : 599-605

Bentham Science Publishers

Access to resources Recommend Favorite